The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Kenji Hashimoto

Division of Clinical Neuroscience

Chiba University Center for Forensic Mental Health

1-8-1 Inohana

Chiba 260-8670

Japan

[email]@*.chiba-u.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 1-8-1 Inohana, Chiba 260-8670, Japan. 2006 - 2012
  • Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan. 2007 - 2008

References

  1. Sigma-1 receptor agonists as therapeutic drugs for cognitive impairment in neuropsychiatric diseases. Niitsu, T., Iyo, M., Hashimoto, K. Curr. Pharm. Des. (2012) [Pubmed]
  2. Role of the mTOR signaling pathway in the rapid antidepressant action of ketamine. Hashimoto, K. Expert. Rev. Neurother (2011) [Pubmed]
  3. Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazol. Hashimoto, K., Ishima, T. PLoS. ONE (2011) [Pubmed]
  4. Glycine transporter-1: a new potential therapeutic target for schizophrenia. Hashimoto, K. Curr. Pharm. Des. (2011) [Pubmed]
  5. A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation [corrected] factor eIF4AI. Hashimoto, K., Ishima, T. PLoS. ONE (2010) [Pubmed]
  6. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Hashimoto, K. Psychiatry Clin. Neurosci. (2010) [Pubmed]
  7. A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia. Shiina, A., Shirayama, Y., Niitsu, T., Hashimoto, T., Yoshida, T., Hasegawa, T., Haraguchi, T., Kanahara, N., Shiraishi, T., Fujisaki, M., Fukami, G., Nakazato, M., Iyo, M., Hashimoto, K. Ann. Gen. Psychiatry (2010) [Pubmed]
  8. Emerging role of glutamate in the pathophysiology of major depressive disorder. Hashimoto, K. Brain. Res. Rev (2009) [Pubmed]
  9. Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. Hashimoto, K. Cent. Nerv. Syst. Agents. Med. Chem (2009) [Pubmed]
  10. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Hashimoto, K., Fujita, Y., Horio, M., Kunitachi, S., Iyo, M., Ferraris, D., Tsukamoto, T. Biol. Psychiatry (2009) [Pubmed]
  11. Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia? Hashimoto, K. CNS. Neurol. Disord. Drug. Targets (2009) [Pubmed]
  12. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and D-serine. Hashimoto, K., Fujita, Y., Ishima, T., Chaki, S., Iyo, M. Eur. Neuropsychopharmacol (2008) [Pubmed]
  13. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective alpha7 nicotinic receptor agonist SSR180711. Hashimoto, K., Ishima, T., Fujita, Y., Matsuo, M., Kobashi, T., Takahagi, M., Tsukada, H., Iyo, M. Biol. Psychiatry (2008) [Pubmed]
  14. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys. Hashimoto, K., Nishiyama, S., Ohba, H., Matsuo, M., Kobashi, T., Takahagi, M., Iyo, M., Kitashoji, T., Tsukada, H. PLoS. ONE (2008) [Pubmed]
  15. Association study between polymorphisms in glutathione-related genes and methamphetamine use disorder in a Japanese population. Hashimoto, T., Hashimoto, K., Miyatake, R., Matsuzawa, D., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., Yamada, M., Sora, I., Ujike, H., Iyo, M. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2008) [Pubmed]
  16. Increased levels of glutamate in brains from patients with mood disorders. Hashimoto, K., Sawa, A., Iyo, M. Biol. Psychiatry (2007) [Pubmed]
  17. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Tsuchiya, K.J., Hashimoto, K., Iwata, Y., Tsujii, M., Sekine, Y., Sugihara, G., Matsuzaki, H., Suda, S., Kawai, M., Nakamura, K., Minabe, Y., Yagi, A., Iyo, M., Takei, N., Mori, N. Biol. Psychiatry (2007) [Pubmed]
  18. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Hashimoto, K., Fujita, Y., Iyo, M. Neuropsychopharmacology (2007) [Pubmed]
  19. Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a positron emission tomography study in conscious monkeys. Hashimoto, K., Tsukada, H., Nishiyama, S., Fukumoto, D., Kakiuchi, T., Iyo, M. Biol. Psychiatry (2007) [Pubmed]
  20. Glycine transporter inhibitors as therapeutic agents for schizophrenia. Hashimoto, K. Recent. Pat. CNS. Drug. Discov (2006) [Pubmed]
 
WikiGenes - Universities